163 related articles for article (PubMed ID: 27184093)
1. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer.
Vachani A; Whitney DH; Parsons EC; Lenburg M; Ferguson JS; Silvestri GA; Spira A
Chest; 2016 Jul; 150(1):210-8. PubMed ID: 26896702
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.
Lee HJ; Mazzone P; Feller-Kopman D; Yarmus L; Hogarth K; Lofaro LR; Griscom B; Johnson M; Choi Y; Huang J; Bhorade S; Spira A; Kennedy GC; Wahidi MM;
Chest; 2021 Jan; 159(1):401-412. PubMed ID: 32758562
[TBL] [Abstract][Full Text] [Related]
4. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
[TBL] [Abstract][Full Text] [Related]
5. Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.
Sethi S; Oh S; Chen A; Bellinger C; Lofaro L; Johnson M; Huang J; Bhorade SM; Bulman W; Kennedy GC
BMC Pulm Med; 2022 Jan; 22(1):26. PubMed ID: 34991528
[TBL] [Abstract][Full Text] [Related]
6. Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy.
Raval AA; Benn BS; Benzaquen S; Maouelainin N; Johnson M; Huang J; Lofaro LR; Ansari A; Geurink C; Kennedy GC; Bulman WA; Kurman JS
Respir Med; 2022; 204():106990. PubMed ID: 36283245
[TBL] [Abstract][Full Text] [Related]
7. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
[TBL] [Abstract][Full Text] [Related]
8. Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.
Johnson MK; Wu S; Pankratz DG; Fedorowicz G; Anderson J; Ding J; Wong M; Cao M; Babiarz J; Lofaro L; Walsh PS; Kennedy GC; Huang J
BMC Cancer; 2021 Apr; 21(1):400. PubMed ID: 33849470
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
[TBL] [Abstract][Full Text] [Related]
10. Factors that influence physician decision making for indeterminate pulmonary nodules.
Vachani A; Tanner NT; Aggarwal J; Mathews C; Kearney P; Fang KC; Silvestri G; Diette GB
Ann Am Thorac Soc; 2014 Dec; 11(10):1586-91. PubMed ID: 25386795
[TBL] [Abstract][Full Text] [Related]
11. Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.
Mazzone P; Dotson T; Wahidi MM; Bernstein M; Lee HJ; Feller Kopman D; Yarmus L; Whitney D; Stevenson C; Qu J; Johnson M; Walsh PS; Huang J; Lofaro LR; Bhorade SM; Kennedy GC; Spira A; Rivera MP; ;
PLoS One; 2022; 17(7):e0268567. PubMed ID: 35830375
[TBL] [Abstract][Full Text] [Related]
12. A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost-effectiveness analysis.
D'Andrea E; Choudhry NK; Raby B; Weinhouse GL; Najafzadeh M
Int J Cancer; 2020 Feb; 146(3):781-790. PubMed ID: 30977121
[TBL] [Abstract][Full Text] [Related]
13. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
[TBL] [Abstract][Full Text] [Related]
14. Application of a classifier combining bronchial transcriptomics and chest computed tomography features facilitates the diagnostic evaluation of lung cancer in smokers and nonsmokers.
Xia Y; Ying S; Jin R; Wu H; Shen Y; Yin T; Yan F; Zhang W; Lan F; Zhang B; Zhu C; Li C; Li W; Shen H
Int J Cancer; 2021 Sep; 149(6):1290-1301. PubMed ID: 33963762
[TBL] [Abstract][Full Text] [Related]
15. Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy.
Yung RC
Respir Care Clin N Am; 2003 Mar; 9(1):51-76. PubMed ID: 12820712
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of endobronchial and endoscopic ultrasound-guided fine needle aspiration for accessible lung cancer lesions after non-diagnostic conventional techniques: a prospective study.
Bugalho A; Ferreira D; Eberhardt R; Dias SS; Videira PA; Herth FJ; Carreiro L
BMC Cancer; 2013 Mar; 13():130. PubMed ID: 23510132
[TBL] [Abstract][Full Text] [Related]
17. Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.
Raghu G; Flaherty KR; Lederer DJ; Lynch DA; Colby TV; Myers JL; Groshong SD; Larsen BT; Chung JH; Steele MP; Benzaquen S; Calero K; Case AH; Criner GJ; Nathan SD; Rai NS; Ramaswamy M; Hagmeyer L; Davis JR; Gauhar UA; Pankratz DG; Choi Y; Huang J; Walsh PS; Neville H; Lofaro LR; Barth NM; Kennedy GC; Brown KK; Martinez FJ
Lancet Respir Med; 2019 Jun; 7(6):487-496. PubMed ID: 30948346
[TBL] [Abstract][Full Text] [Related]
18. Comparing modalities for risk assessment in patients with pulmonary lesions and nondiagnostic bronchoscopy for suspected lung cancer.
Yu DH; Shafiq M; Batra H; Johnson M; Griscom B; Chamberlin J; Lofaro LR; Huang J; Bulman WA; Kennedy GC; Yarmus LB; Lee HJ; Feller-Kopman D
BMC Pulm Med; 2022 Nov; 22(1):442. PubMed ID: 36434574
[TBL] [Abstract][Full Text] [Related]
19. The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.
Lasky JA; Case A; Unterman A; Kreuter M; Scholand MB; Chaudhary S; Lofaro LR; Johnson M; Huang J; Bhorade SM; Kennedy GC
Ann Am Thorac Soc; 2022 Jun; 19(6):916-924. PubMed ID: 34889723
[No Abstract] [Full Text] [Related]
20. Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules.
Vachani A; Hammoud Z; Springmeyer S; Cohen N; Nguyen D; Williamson C; Starnes S; Hunsucker S; Law S; Li XJ; Porter A; Kearney P
Lung; 2015 Dec; 193(6):1023-7. PubMed ID: 26376647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
